Circulatory system

Post-traumatic Stress Disorder Treatment Market - Global Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Retrieved on: 
Tuesday, January 24, 2023
Veteran, Safety, GlobalPost, PTSD, American Psychiatric Association, Fluoxetine, Marketing, Nightmare, Post-traumatic stress disorder, Route of administration, Sertraline, Paroxetine, Region, Jazz Pharmaceuticals, US, Insomnia, Growth, FAAH, Trauma, Thought, Sudden death, Market, Vietnam War, Circulatory system, Patient, Woman, Anxiety, Administration, Research, Distribution, Pharmaceutical industry, Meat

DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Post-traumatic Stress Disorder Treatment Market, by Drug Class, by Route of Administration, by Age Group, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Post-traumatic stress disorder (PTSD) is a psychiatric condition that may occur in people who have witnessed a traumatic shock like natural disaster, a life threatening event, car accident, sexual abuse etc.
  • Commonly prescribed drugs for post trauma stress disorder includes antidepressants, sertraline, fluoxetine, paroxetine, and others.
  • Increasing research and development activities by the key market players for the treatment of post-traumatic stress disorder is expected to boost the growth of the global post-traumatic stress disorder treatment market over the forecast period.

Global Surgical Imaging Market Forecast Report 2023-2027 Featuring Leading Players - GE Healthcare, Siemens, Medtronic, Koninklijke Philips, Hitachi, Hologic, Fujifilm Medical Systems, and Geonoray - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 12, 2023
Surgery, Health, Hospital, Neuro, Urology, FPD, R, Cancer, COVID-19, Siemens, GE Healthcare, Trauma, Conditional sentence, Google Images, Critical care, Health, Diagnosis, Spine, Blood vessel, Kidney, Hologic, Patient, Prevalence, Hitachi, Circulatory system, US, Medtronic, Incidence, Obesity, Dentistry, Medical imaging, Medical device, Pharmaceutical industry, Gastroenteritis, Growth

The "Surgical Imaging Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Surgical Imaging Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Hence, an increase in the prevalence of chronic diseases will boost the surgical imaging market during the forecast period.
  • Additionally, the Cardiovascular segment will also grow during the forecast period owing to the technological advancement in surgical imaging.
  • GE Healthcare, Siemens AG, Medtronic Plc., Koninklijke Philips, Hitachi Ltd., Hologic Inc., Fujifilm Medical Systems, and Geonoray Co. Ltd. are the leading players in the surgical imaging market.

Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP

Retrieved on: 
Tuesday, January 10, 2023
Professional corporation, Cardiovascular disease, United Kingdom, Physician, Bachelor of Medicine, Bachelor of Surgery, Amarin Corporation, Consultant, GlaxoSmithKline, International, National Health Service, Metabolism, Royal college, Patient, Diabetes, University of Southampton School of Medicine, Circulatory system, GSK, NHS, Management, Pharmaceutical industry, Medicine, Obesity

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Murray W. Stewart, D.M., F.R.C.P., has been appointed to the Company’s Board of Directors. Following the appointment of Dr. Stewart, the Amarin Board will be made up of approximately 70 percent of new independent directors who were named to the Board over the last 12 months.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Murray W. Stewart, D.M., F.R.C.P., has been appointed to the Company’s Board of Directors.
  • Following the appointment of Dr. Stewart, the Amarin Board will be made up of approximately 70 percent of new independent directors who were named to the Board over the last 12 months.
  • “As we focus on launching in Europe and diversifying our product portfolio, adding Dr. Stewart to our Board brings exceptional expertise in cardiometabolic research and clinical development,” said Per Wold-Olsen, Chairman of the Board of Directors, Amarin.
  • As part of the Company’s focus on stronger corporate governance, Amarin has named six new members to the Company’s board of directors over the last 12 months, including Dr. Murray Stewart.

Global Regenerative Medicine Market Report 2022 to 2027: Players Include 3M, Allergan, Amgen and Anterogen Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 28, 2022
Health, Pharmaceutical, Molecule, Ansoff Matrix, Circulatory system, Regenerative medicine, SWOT, USD, 3D bioprinting, Porter's five forces analysis, Risk, Growth, Impact, Investment, Tissue engineering, Competitive analysis, COVID-19, Emotion, Cell, Observation, Market development, Geography, Pharmaceutical industry, Retail, Risk management, Medical imaging, Diabetes

The Global Regenerative Medicine Market is estimated to be USD 19.95 Bn in 2022 and expected to reach USD 48.7 Bn by 2027, growing at a CAGR of 19.54%.

Key Points: 
  • The Global Regenerative Medicine Market is estimated to be USD 19.95 Bn in 2022 and expected to reach USD 48.7 Bn by 2027, growing at a CAGR of 19.54%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Regenerative Medicine Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Regenerative Medicine Market.
  • The report offers a comprehensive evaluation of the Global Regenerative Medicine Market.

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

Retrieved on: 
Friday, December 9, 2022
CV, Mechanics, Heart failure, Intellectual property, Cytokinetics, Hospital, SAN, Pharmacology, Prescription Drug User Fee Act, Systole, Security (finance), ALS, FDA, Marketing, Circulatory system, Sale, HCM, Muscle weakness, PDUFA, Heart, Death, New Drug Application, Prognosis, Safe harbor, The Act, Amyotrophic lateral sclerosis, NDA, Act, History, Patent, Standard of care, Risk, Patient, Pharmaceutical industry

The advisory committee meeting, which is being held virtually, is scheduled to begin at 9:00 AM ET on December 13, 2022.

Key Points: 
  • The advisory committee meeting, which is being held virtually, is scheduled to begin at 9:00 AM ET on December 13, 2022.
  • The Company is not responsible for the content of, nor the statements made in, the briefing materials that were prepared by the FDA.
  • The NDA for omecamtiv mecarbil is based on the results from GALACTIC-HF, the Phase 3 clinical trial of omecamtiv mecarbil.
  • For further information regarding these and other risks related to Cytokinetics' business, investors should consult Cytokinetics' filings with the Securities and Exchange Commission.

Europe Fitness Equipment Market Outlook to 2027 - Featuring Life Fitness, Johnson Health Tech, Nautilus and Technogym Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 13, 2022
Fitness & Nutrition, Health, Anytime Fitness, CORE Health Care, Health, Heart, United Kingdom, Fitness, Duke Diet and Fitness Center, Degenerative disease, Exercise, Armies of Exigo, Octane Fitness, LLC v. ICON Health & Fitness, Inc., Nautilus, Inc., Respiratory system, Disease, Life Fitness, Physical fitness, Obesity, Circulatory system, Growth, Heart rate, Burn, Arthritis, Johnson Health Tech, Human, Sport, Infarction, Blood pressure, USD, Salter, Dietary supplement, Fine chemical, Fashion, Torque

This report provides an all-round analysis of Europe's fitness equipment market with the historical and forecasted performance of its segments.

Key Points: 
  • This report provides an all-round analysis of Europe's fitness equipment market with the historical and forecasted performance of its segments.
  • Europe is the second biggest market in the fitness equipment category, which has been majorly driven by higher member penetration in health & fitness clubs.
  • Moreover, the emergence of the equipment manufacturing companies like Core Health & Fitness, Johnson Health Tech, Exigo, Torque fitness LLC, and others as a leading B2B manufacturing company.
  • Icon Health & Fitness Inc, Life Fitness, Johnson Health Tech Co. Ltd, Nautilus INC, Technogym S.P.A, Amer Sports Corporation, Core Health & Fitness LLC, Precor Incorporated, Tuntari New Fitness B.V, Exigo, Body Solid Europe, Rough Fitness, SportsArt Fitness, Inc., BFT Fitness

PTA Balloon Catheter Market Report 2022: Increasing Prevalence of Cardiovascular Disease Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 8, 2022
Health, Surgery, Cardiology, Medical Devices, Degenerative disease, Arm, Leg, Medtronic, Boston Scientific, CVD, Cardinal Health, Global Health, Skin, Prevalence, Dilation, US, BD (company), PTA, LASI, Femoral artery, Death, Circulatory system, Growth, Application, Marketing, Region, Radial artery, Cardiovascular disease, Cook Group, Renewable energy, Pharmaceutical industry, Synthetic rubber

The "PTA Balloon Catheter Market, by Material Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "PTA Balloon Catheter Market, by Material Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • PTA balloon catheter is an innovative medical device, which is inserted in the femoral artery in the leg or sometimes into the radial artery in the arm for the treatment of constricted blood vessels.
  • As the balloon inflates, the cage causes the balloon to form a series of segmented pillows and grooves along the entire lesion.
  • The standard PTA balloon catheter segment has represented the largest share of the total PTA balloon catheter market.

Middle East & Africa Fitness Equipment Market Report to 2027 - Featuring Icon Health & Fitness, Life Fitness, Johnson Health Tech and Technogym Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 7, 2022
Fitness & Nutrition, Health, Health, Culture, United Arab Emirates, Fitness First, Duke Diet and Fitness Center, Stroke, Exercise, Octane Fitness, LLC v. ICON Health & Fitness, Inc., Life Fitness, Diabetes, Literacy, Obesity, Government, Circulatory system, Growth, Education, World Gym, Traction, Gold's Gym, Coffee, Interior design

The "Middle East & Africa Fitness Equipment (Cardiovascular & Strength) Market Outlook, 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Middle East & Africa Fitness Equipment (Cardiovascular & Strength) Market Outlook, 2027" report has been added to ResearchAndMarkets.com's offering.
  • This report provides a complete analysis of the fitness equipment market with its historical and forecasted performance.
  • which have provided strong growth in the Middle East & Africa region's strength fitness equipment market.
  • Icon Health & Fitness Inc, Life Fitness, Johnson Health Tech Co. Ltd, Technogym S.P.A, Precor Incorporated, SportsArt Fitness, Inc., BFT Fitness, Dubai Sports LLC

Oncotelic Reports Q3 2022 Compared to Q3 2021 Financial Results

Retrieved on: 
Monday, November 21, 2022
HSDD, Female, Cocaine, ED, Sertraline, Communication, PPP, Apomorphine, Food, Cancer, Hartmut Geerken, G&A, Mohammad Ali Allahdadi, Safety, Therapy, Melanoma, Orthostatic syncope, Patient, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, CA4P, Optimism, Oxigen Services, Parkinson's disease, Disease, Fluoxetine, McMahon, Annual report, BARDA, Diffuse intrinsic pontine glioma, Male, Hypotension, PD, Research, Risk, BMJ, Ageing, PDE5, KJ, Circulatory system, Clinical trial, JV, Survival, Erectile dysfunction, Form 10-K, Woman, FSD, Manifest and latent functions and dysfunctions, Pharmaceutical industry, Bremelanotide

In comparing the Companys operating results for the three months ended September 30, 2022, and 2021, respectively, our net loss reduced by approximately $1.0 million.

Key Points: 
  • In comparing the Companys operating results for the three months ended September 30, 2022, and 2021, respectively, our net loss reduced by approximately $1.0 million.
  • Further, our general and administrative expenses decreased by approximately $0.6 million primarily due to reduced compensation expense of approximately $0.6 million.
  • We expect our R&D and G&A expense to remain steady or reduce for the remainder of the year 2022.
  • Oncotelic acquired AL-101, during the 4th quarter of 2021, for the intranasal delivery of apomorphine.

Implicity to Participate in Health Tech Challengers Super Finals at HLTH 2022

Retrieved on: 
Tuesday, November 8, 2022
Food, Medtech, Patient, Cardiology, Algorithm, Johnson Health Tech, CI, No. 166 Squadron RAF, Venture capital, Ecosystem, Workload, ECG, Circulatory system, Criticism of the Food and Drug Administration, Research, Degenerative disease, Heart, HTC, CEO, Medical device, Implications of U.S. gene patent invalidation on Australia

CAMBRIDGE, Mass., Nov. 8, 2022 /PRNewswire/ -- Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced it has been selected to participate in the Health Tech Challengers (HTC) Super Finals taking place live at HLTH 2022.

Key Points: 
  • Company named a Top 8 Super Finalist in the global health tech competition identifying the most disruptive companies shaping the future of digital health.
  • CAMBRIDGE, Mass., Nov. 8, 2022 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, announced it has been selected to participate in the Health Tech Challengers (HTC) Super Finals taking place live at HLTH 2022.
  • Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, which reduce the workload on healthcare professionals.
  • Implicity proudly protects more than 60,000 patients in 100 medical facilities across the United States and Europe.For more information, visit: www.implicity.com .